EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities.
Yedier-Bayram O, Gokbayrak B, Kayabolen A, Aksu AC, Cavga AD, Cingöz A, Kala EY, Karabiyik G, Günsay R, Esin B, Morova T, Uyulur F, Syed H, Philpott M, Cribbs AP, Kung SHY, Lack NA, Onder TT, Bagci-Onder T.
Yedier-Bayram O, et al. Among authors: cavga ad.
Cell Death Dis. 2022 Aug 16;13(8):710. doi: 10.1038/s41419-022-05146-4.
Cell Death Dis. 2022.
PMID: 35973998
Free PMC article.